期刊文献+

珊瑚/胶原/重组人骨形成蛋白—2复合人工骨修复兔颅骨缺损 被引量:1

HEALING OF RABBIT CALVARLAL DEFECTS IS AIDED BY CORAL/COLLAGEN/rhBMP 2 COMPOSITE
下载PDF
导出
摘要 为评价珊瑚/胶原/重组人工骨形成蛋白-2复合人工骨(简称复合骨)的骨修复能力,将复合骨植入兔颅骨直径15mm的圆形缺损,以单纯珊瑚植入作对照;术后6周、12周取材,通过组织学观察和计算机图像分析,评价其骨修复能力。发现复合骨植入区形成的骨组织量明显多于同期的珊瑚植入区(P〈0.01);术后12周,复合骨完全被成熟的骨组织取代,其骨修复效果明显优于单纯的珊瑚。说明复合骨具有骨传导和骨诱导活性。 By combining coral with collagen and recombinant human bone morphogenetic protein 2(rhBMP 2), coral/collagen/rhBMP 2 composite was obtained. The composite was implanted into rabbit calvarial critical size defects, plain coral used as control. The animals were sacrificed at 6 and 12 weeks respectively after operation, and specimens were removed and examined by histology and image analysis system. Following implantation of the composite, lamellar bone was shown in all coral pores at 6 weeks, and the composite was absorbed and replaced completely by mature bone at 12 weeks. Following implantation of plain coral, lamellar bone was shown in periphery coral pores in the bone defect, while fibrous tissue invased into the central coral pores and bone was not observed there at 6 weeks, and coral was absorbed completely and replaced by bone and fibrous tissue at 12 weeks. The bone repairing ability and effect of the composite were better than those of coral. This study implies that the coral/collagen/rhBMP 2 composite possesses definitively osteoindutive and osteoconductive activity and better bone repairing ability. The composite appears to be an ideal biomaterial for the repair of bone defects.
出处 《南京大学学报(自然科学版)》 CAS CSCD 1999年第5期549-553,共5页 Journal of Nanjing University(Natural Science)
关键词 珊瑚 胶原 骨形成蛋白 修复 人工骨 颅骨缺损 Coral, Collagen, Bone morphogenetic protein, Bone defect
  • 相关文献

同被引文献16

  • 1Kingsley D M. The TGF-beta superfamily: New members, new receptors, and new genetic tests of function in different organisms. Genes Development, 1994, 8: 133-146.
  • 2Wang E A, Rosen V, D'Alessandro J S, et al. Recombinant human bone morphogenetic protein induces bone formation. Proceedings of National Academy of Science of USA, 1990, 87: 2220- 2224.
  • 3Wozney J M, Rosen V, Celeste A J, et al. No vel regulators of bone formation: Molecular clones and activities. Science, 1988, 242:1528-1534.
  • 4Hogan B L. Bone morphogenetic proteins: Multifunctional regulators of vertebrate development. Genes Development, 1996, 10: 1580- 1594.
  • 5Scheuxer C, Sebald W, Hulsmeyer M. Crystal structure of human bone morphogenetie protein- 2 at 2.7 A resolution. Journal of Molecular Biology, 1999, 287: 103-115.
  • 6Boden S D, Zdeblick T A, Sandhu H S, et al. The use of rhBMP-2 in interbody fusion cages, defnitive evidence of osteoinduction in human: A preliminary report. Spine, 2000, 25: 376-381.
  • 7Kirker-Head C A. Potential applications and delivery strategies for bone morphogenetic proteins. Advanced Drug Delivery Reviews, 2000, 43: 65-92.
  • 8Wang E A, Rosen V, Cordes P, et al. Purification and characterization of other distinct bone-inducing factors. Proceedings of National Academy of Science of USA, 1988, 85: 9484-9488.
  • 9Bessho K, Kusumoto K, Fujimura K, et al. Comparison of recombinant and purified human hone morphogenetic protein. British Journal of Oral Maxillofacial Surgery, 1999, 37: 2-5.
  • 10Cerletti N, McMaster G K, Cox D, et al. Process for the production of biologically active protein (e. g. TGF). Patent Application No. EP0433225A1 (granted 07.04.99), 1991.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部